Skip to content

Closure of the Uterine Artery at Its Origin vs at the Cervix: a Randomized Trial

Closure at the Origin of the Uterine Artery vs. Closure at the Cervico-isthmic Level in Laparoscopic Hysterectomy: a Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04156932
Enrollment
200
Registered
2019-11-08
Start date
2019-12-01
Completion date
2020-08-31
Last updated
2021-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anatomy, Hysterectomy, Laparoscopy, Uterine Artery

Brief summary

One of the fundamental surgical steps in patients undergoing laparoscopic hysterectomy is the closure of the uterine artery, this vessel provides the greatest blood supply to the uterus. This step can be done in two ways: the surgeon can choose to interrupt the blood flow by closing the uterine artery in its last part, close to the uterus, or the surgeon can develop the anatomical spaces around the uterus into the deep pelvis, closing it to its origin, maintaining a minimally invasive approach in both cases. Scientific research has tried to establish whether one of the two modalities is the best in reducing intraoperative blood loss and possible complications, but currently there is not enough evidence to recommend an approach rather than another. The investigator has therefore decided to evaluate the results at the end of a laparoscopic hysterectomy in a scientifically rigorous manner.

Interventions

PROCEDUREuterine artery closure

Interruption the uterine blood flow by closing the uterine artery at its cervical-isthmic part or at its origin.

Sponsors

Ospedale degli Infermi di Biella
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* benign disease * elective laparoscopic hysterectomy

Exclusion criteria

* malignant disease * emergency laparoscopic hysterectomy

Design outcomes

Primary

MeasureTime frameDescription
estimated blood lossEnd of surgical procedureml

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026